Aktie A3EV5Z J. B. CHEMICALS & PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen J. B. Chemicals & Pharmaceuticals Limited NSE India S.E.

Aktien

A3EV5Z

INE572A01036

JBCHEPHARM

Verzögert NSE India S.E.
Andere Börsenplätze
 11:22:55 22.05.2024 		% 5 Tage % 1. Jan.
1’700 INR -4.15% Intraday Chart für J. B. Chemicals & Pharmaceuticals Limited -5.84% +4.64%
21.05. Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q4 2024 Earnings Call, May 21, 2024
17.05. J. B. Chemicals & Pharmaceuticals Limited meldet Ergebnis für das vierte Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
J. B. Chemicals & Pharmaceuticals Limited Recommends Final Dividend for the Year 2023-2024
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
KKR to buy India's Healthium Medtech at $839 million valuation, sources say
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Joint Commissioner State Tax, Lucknow II, Lucknow
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Assessment Unit, Income Tax Department
J. B. Chemicals & Pharmaceuticals Limited Announces Demise of Ranjit Shahani, Chairman and Non-Executive, Independent Director
KKR Reportedly Considers Selling Controlling Stake in JB Pharma
JB Chemicals' Consolidated Profit Climbs in Fiscal Q3; Shares Jump 4%
J.B. Pharma Seeks Acquisitions
J. B. Chemicals & Pharmaceuticals Appoints CFO
JB Chemicals Names CFO
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
J. B. Chemicals & Pharmaceuticals Limited Appoints Narayan Saraf as the Chief Financial Officer, with Effect from February 23, 2024
J. B. Chemicals & Pharmaceuticals Limited Declares Interim Dividend for Financial Year 2023-24
J B Chemicals & Pharmaceuticals : Earnings Call Transcript – Entry into Ophthalmology segment
J. B. Chemicals & Pharmaceuticals Limited Announces Execution of Trade Mark License Agreement with Novartis Innovative Therapies Ag and Promotion & Distribution Agreement with Novartis Healthcare Private Limited
JB Pharma Seeks Acquisitions
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EV5Z Aktie
  4. A3EV5Z Aktie
  5. Nachrichten J. B. Chemicals & Pharmaceuticals Limited
  6. Andere Sprachen